Dr. Evan Wood, MD, PhD, British Columbia Node NPI
The CRISM BC Node is led by Dr. Evan Wood, Director of the British Columbia Centre on Substance Use and Professor of Medicine at the University of British Columbia. The BC Node is an interdisciplinary expert network of over 100 contributing members, including advocacy groups, policy makers, service providers, and research scientists. The network is affiliated with the BC Centre on Substance Use, the University of British Columbia, and Simon Fraser University, and other institutions, and works closely with regional health authorities and the provincial government. Through the translation of scientific evidence into practice and policy change, the network promotes evidence-based approaches to addiction treatment and provides training to the next generation of leaders through our comprehensive education programs.
To ensure that research priorities align with lived experience of those affected by substance use disorders, we have well-established partnerships with community and advocacy groups, including the BC Association of People on Methadone (BCAPOM), the Vancouver Area Network of Drug Users (VANDU), the Western Aboriginal Harm Reduction Society (WAHRS), From Grief to Action (FGTA), and Moms Stop the Harm. Our linkages to treatment providers, health system administrators and government policy-makers, our training infrastructure, and our national and international collaborations ideally position us to undertake collaborative research and implementation of evidence-based therapeutic approaches.
Dr. Cameron Wild, PhD, Prairies Node NPI
The Prairie Node includes Alberta, Saskatchewan, and Manitoba, and is led by Dr. Cameron Wild, Professor at the University of Alberta. Excellent researchers from Alberta, Saskatchewan, and Manitoba are investigating substance misuse/addiction interventions delivered in clinics, the community, and academic research settings. Each province funds treatment and prevention of substance misuse/addiction and has developed strategic plans through their respective Ministries of Health and Regional Health Authorities. But to date these assets have operated either in isolation or as part of small provincial teams.
The CRISM Prairie Node already counts over 300 members, including investigators, system and program managers, policy makers, and consumer advocates, each of whom recognizes the need for enhanced regional collaboration to address substance misuse/addiction, and who have committed to participate in a Prairie regional CRISM Node.
Dr. Jürgen Rehm, PhD, Ontario Node NPI
The Ontario Node is led by Dr. Jürgen Rehm, Senior Scientist in the Institute for Mental Health Policy Research (IMHPR) and the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH), in Toronto, Ontario. The Ontario Node is comprised of an interdisciplinary team of members including academic investigators, community-based intervention providers, system/policy representatives, advocacy groups and people with lived experience from across Ontario. OCRINT is affiliated with CAMH as well as a number of other institutions, and works closely with provincial health authorities, policy makers and government to promote evidence-based approaches to addiction treatment.
OCRINT's members share and translate knowledge and scientific evidence related to interventions for substance misuse with the goal of improving intervention and systems, as well as collaborate and commmunicate to work towards improving the lives and health of those living with substance misuse.
Dr. Julie Bruneau, MD, MSC, Quebec-Atlantic Node NPI
The Québec-Atlantic Node is led by Dr. Julie Bruneau, Professor at the University of Montréal. The Québec-Atlantic Node combines the expertise of researchers, clinicians, and knowledge users from Québec and the Atlantic provinces. Members aim to identify the specific needs and priorities of these provinces (Québec, New Brunswick, Nova Scotia, Newfoundland and Labrador, and Prince Edward Island) and generate evidence-based knowledge according to real needs through research and collaborative projects. This node also contributes to the development of interventional research-based practices and policies with a Canada-wide perspective in mind, to ultimately improve quality of care and quality of life for all Canadians living with substance misuse.
Node members are working on multiple projects aimed at accelerating the transfer of scientific knowledge into better addiction treatment approaches, including both pharmaceutical and psychological interventions. In addition, they benefit from multidisciplinary expertise brought by the diversity of researchers, service providers, and service users who joined the node and are addressing the substance misuse issue from different angles. This vision has the potential to accelerate knowledge base translation into practice and ameliorate the health and well-being of persons living with substance misuse.